Although this study lacks validation in an independent cohort, HMGB1 and the HMGB1/sRAGE ratio clearly seem to be promising and easily accessible biomarkers for the detection of ovarian cancer and possibly even for benign ovarian diseases. The gene discussed is HMGB1; the disease is ovarian carcinoma.